Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,887 | 4,983 | 287 | 1,661 | 49 |
| Receivables | 421 | 669 | 455 | 44 | 335 |
| TOTAL | $4,343 | $5,673 | $742 | $1,724 | $406 |
| Non-Current Assets | |||||
| PPE Net | 7 | 1 | 1 | 2 | 2 |
| Intangibles | 5,693 | 5,754 | 0 | 0 | 0 |
| TOTAL | $5,700 | $5,755 | $1 | $2 | $2 |
| Total Assets | $10,043 | $11,428 | $744 | $1,726 | $408 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,679 | 1,723 | 1,027 | 1,517 | 968 |
| TOTAL | $1,679 | $1,723 | $1,027 | $1,517 | $968 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 896 | N/A | N/A |
| TOTAL | $N/A | $N/A | $896 | $N/A | $N/A |
| Total Liabilities | $1,679 | $1,723 | $1,924 | $1,517 | $968 |
| Shareholders' Equity | |||||
| Common Shares | 22,593 | 22,629 | 3,893 | 25,363 | 22,223 |
| Retained earnings | -16,190 | -14,112 | -5,299 | -30,994 | -28,718 |
| Other shareholders' equity | -1 | 0 | 0 | 658 | 1,052 |
| TOTAL | $8,364 | $9,706 | $-1,180 | $209 | $-560 |
| Total Liabilities And Equity | $10,043 | $11,428 | $744 | $1,726 | $408 |